drugset
drugset / Trial / NCT01477411

A Drug-Drug Interaction Study of Digoxin and PA21

NCT01477411 ↗

Phase 1 Completed 42 enrolled Vifor Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if Digoxin is affected by PA21.

Timeline

Start
2011-11
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.5 mg —
Subject PA21 Unknown 15 g —

Indications

No indication recorded.